China National Accord Medicines Corporation Ltd. (SHE:000028)
China flag China · Delayed Price · Currency is CNY
19.47
-0.37 (-1.86%)
Aug 21, 2026, 3:04 PM CST

SHE:000028 Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
1,136642.491,5991,4871,336
Depreciation & Amortization
1,2291,5451,4261,3071,242
Other Amortization
200.02198.4163.56180.31188.65
Loss (Gain) From Sale of Assets
-7.96-11.87-45.31-6.26-2.7
Asset Writedown & Restructuring Costs
285.76971.840.6355.64236.84
Loss (Gain) From Sale of Investments
-294.38-356.87-309.08-28.87-
Provision & Write-off of Bad Debts
83.9594.1571.3629.7744.22
Other Operating Activities
197.59-119.54630.83357.4131.94
Change in Accounts Receivable
-1,484-965.33-3,9921,227-2,121
Change in Inventory
-721.59559.6-170.13-217.84-1,260
Change in Accounts Payable
1,309463.053,688-1,9492,135
Change in Other Net Operating Assets
-213.62305.42-79.9193.22-203.6
Operating Cash Flow
1,6393,2712,9372,5601,655
Operating Cash Flow Growth
-49.91%11.38%14.71%54.69%10.14%

Investing Activities

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-217.35-282.7-322.21-322.19-370.43
Sale of Property, Plant & Equipment
1.821.237.884.941.02
Cash Acquisitions
-7.42-71.4--126.35-109.95
Divestitures
--3.23--
Investment in Securities
20.946.58-3.7289.66-144.03
Other Investing Activities
99.09195.63149.3811.12167.86
Investing Cash Flow
-102.92-150.69-135.43-342.82-455.53

Financing Activities

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Short-Term Debt Issued
1,6721,5601,873-81.45
Long-Term Debt Issued
--41,520932.68
Total Debt Issued
1,6721,5601,8771,5201,014
Short-Term Debt Repaid
-1,531-1,575-2,363-72.45-65.7
Long-Term Debt Repaid
-1,026-1,224-1,272-2,629-2,100
Total Debt Repaid
-2,558-2,799-3,635-2,701-2,165
Net Debt Issued (Repaid)
-885.17-1,239-1,758-1,181-1,151
Issuance of Common Stock
--31.6--
Common Dividends Paid
-386.29-603.77-559.07-574.19-610.54
Other Financing Activities
-90.7611.29-121.87247.65-109.86
Financing Cash Flow
-1,362-1,831-2,408-1,508-1,872

Net Cash Flow

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
-0.07-1.2-0.94-1.190.39
Net Cash Flow
173.361,288393.12708.66-671.6

Free Cash Flow

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
1,4212,9892,6152,2381,285
Free Cash Flow Growth
-52.45%14.30%16.83%74.22%6.27%
Free Cash Flow Margin
1.94%4.02%3.46%3.05%1.88%
Free Cash Flow Per Share
2.324.864.273.662.10
Levered Free Cash Flow
2,0141,992877.022,410135.8
Unlevered Free Cash Flow
2,1352,1541,0322,573315.83

Additional Metrics

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Income Tax Paid
1,7361,7711,8871,7821,564
Change in Working Capital
-1,192307.52-599.77-821.69-1,523